Anamarija Rogina was born in 1987. in Zagreb, Croatia and she obtained a PhD in 2015. from the Faculty of Chemical Engineering and Technology, University of Zagreb under the supervision of prof. Marica Ivanković. After doctoral and postdoctoral training at the Polytechnic University of Valencia, Spain, she was promoted to assistant professor at the Faculty of Chemical Engineering and Technology in 2018.

She received the L’Oreal-UNESCO award for ‘Women in Science’ in 2015. and National Annual Science Award for Young Scientist in 2020. According to the researcher database provided by Stanford University (USA), she was among the 2% most cited scientists in the world in 2021.

She is a member of the editorial board of Materials Today Bio  -  1st Early Career Researcher Board (2022. - 2024.) and a member of the editorial board of Polymers MDPI journal.

1.  2023. - 2024. Bioactive composite materials for bone tissue engineering, project co-leader (Bilateral project Croatia - Germany, Croatian Ministry of Science and Education - DAAD. co-leader: Prof. Aldo R. Boccaccini)
2. 2021-2026. Smart drug delivery systems in bone tumour treatment, project leader (Croatian Science Foundation grant no. UIP-2020-02-6201, approx. 245.000 €)
3. 2020-2023. Biodegradable 3D printed structures for bone augmentation, researcher position (EU funds grant no. KK.01.1.1.07.0014, approx. 968.010 €)
4. 2017-2021. Development of biocompatible materials based on hydroxyapatite for bone tissue engineering, researcher position (Croatian Science Foundation grant no. IP-2014-09-3752, approx. 134.000 €)
5. 2016-2017. Polymer blends and composites for biomedical applications, researcher position (Bilateral project Croatia-Slovenia, Croatian Ministry of Science and Education)
6. 2010-2013. Bioceramic, polymer and composite nanostructured materials, researcher position (Croatian Ministry of Science, Education and Sports of the Republic of Croatia grant no. 125-1252970-3005, approx. 40.180 €)

International networking:

2023 - 2027. TEndon Regeneration NETwork (TENET) - COST ACTION CA22170 (Working group  "Biomaterials, cells and molecular therapeutics for advanced tendon therapies")